Hong Kong stock market anomaly | Rongchang Bio (09995.HK) rises more than 4% Vidyasikandra monoclonal antibody combined with Teripril monoclonal antibody Phase III clinical research reached the main research endpoint

According to the Zhitong Finance and Economics APP, Rongchang Biology (09995.HK) has risen by more than 4%. As of the time of this report, it has increased by 4.14% to 39.1 Hong Kong dollars, with a trading volume of 32.6727 million Hong Kong dollars.